Intra-articular Sodium Hyaluronate Injection after Arthroscopic Débridement for Osteoarthritis of the Knee: A Prospective, Randomized, Controlled Study

Phase 4

Completed

• Conditions: osteoarthritis; Musculoskeletal - Osteoarthritis

• Registration Number: ACTRN12608000195358
• Lead Sponsor: Hacettepe University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-04-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

age between 40-65 years, symptomatic primary knee OA according to American College of Rheumatology criteria with a Kellgren-Lawrence (K-L) severity grade of level II or III as determined radiographically at screening.

Exclusion Criteria

•Patients who refused to provide the written informed consent for taking part in the study, agreed to follow study procedures and attend all study visits.
•Patients with previously known bleeding diathesis or coagulation disorder,
•Patients who have any form of contraindication for an arthroscopy procedure,
•Patients with known allergies against chicken or chicken products for intra-articular sodium hyaluronate injection,
•Patients with secondary arthritis, like rheumatoid arthritis or suspected to have any other form of an inflammatory arthritis,
•Patients in whom microfracture” technique was used during AD,
•Patients with major frontal plane deformities,
•Patients with patellar disorder or quadriceps mechanism disorders,
•Patients with advanced level of mental handicap preventing them from fulfilling the study requirements.

Study & Design

• Study Type: Interventional
• Study Design: Not specified